Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19,982 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Heat-shock protein 90α is a potential prognostic and predictive biomarker in hepatocellular carcinoma: a large-scale and multicenter study.
Su K, Liu Y, Wang P, He K, Wang F, Chi H, Rao M, Li X, Wen L, Song Y, Zhang J, Gu T, Xu K, Li Q, Chen J, Wu Z, Li H, Huang W, Chen L, Tong J, Li H, Feng X, Chen S, Yang B, Jin H, Yang Y, Liu H, Yang C, Wu M, Xiong F, Peng K, Zhu L, Xu Y, Tang X, Tan Z, Luo X, Zheng H, Zhang Y, Guo L, Han Y. Su K, et al. Among authors: guo l. Hepatol Int. 2022 Oct;16(5):1208-1219. doi: 10.1007/s12072-022-10391-y. Epub 2022 Aug 16. Hepatol Int. 2022. PMID: 35972640 Free PMC article.
PD-L1 expression on circulating tumor cells can be a predictive biomarker to PD-1 inhibitors combined with radiotherapy and antiangiogenic therapy in advanced hepatocellular carcinoma.
Su K, Guo L, He K, Rao M, Zhang J, Yang X, Huang W, Gu T, Xu K, Liu Y, Wang J, Chen J, Wu Z, Hu L, Zeng H, Li H, Tong J, Li X, Yang Y, Liu H, Xu Y, Tan Z, Tang X, Feng X, Chen S, Yang B, Jin H, Zhu L, Li B, Han Y. Su K, et al. Among authors: guo l. Front Oncol. 2022 Aug 2;12:873830. doi: 10.3389/fonc.2022.873830. eCollection 2022. Front Oncol. 2022. PMID: 35982979 Free PMC article.
PD-1 inhibitors plus anti-angiogenic therapy with or without intensity-modulated radiotherapy for advanced hepatocellular carcinoma: A propensity score matching study.
Su K, Guo L, Ma W, Wang J, Xie Y, Rao M, Zhang J, Li X, Wen L, Li B, Yang X, Song Y, Huang W, Chi H, Gu T, Xu K, Liu Y, Chen J, Wu Z, Jiang Y, Li H, Zeng H, Wang P, Feng X, Chen S, Yang B, Jin H, He K, Han Y. Su K, et al. Among authors: guo l. Front Immunol. 2022 Sep 23;13:972503. doi: 10.3389/fimmu.2022.972503. eCollection 2022. Front Immunol. 2022. PMID: 36211350 Free PMC article.
PD-1 Inhibitors Combined with Antiangiogenic Therapy with or Without Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Propensity Matching Analysis.
Li H, Su K, Guo L, Jiang Y, Xu K, Gu T, Chen J, Wu Z, Wang P, Zhang X, Yan Y, Li S, Wu X, Han L, He K, Wen L, Li B, Han Y. Li H, et al. Among authors: guo l. J Hepatocell Carcinoma. 2023 Jul 29;10:1257-1266. doi: 10.2147/JHC.S415843. eCollection 2023. J Hepatocell Carcinoma. 2023. PMID: 37538403 Free PMC article.
19,982 results
You have reached the last available page of results. Please see the User Guide for more information.